BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B

Amikacin

A broad-spectrum antibiotic derived from KANAMYCIN. It is reno- and oto-toxic like the other aminoglycoside antibiotics.

298+ PubMed studies analyzed · 29 RCTs · Evidence Score: 47.3

Research Domains

Amikacin has been studied across 16 research domains including 🫘 Kidney, 🧠 Focus & Attention, 🔬 Oncology, 🫁 Respiratory, 🫁 Liver & Detox. The primary research focus is 🫘 Kidney with 14% of studies addressing this area.

Loading evidence profile...

This evidence profile for Amikacin is generated deterministically from 298 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.